Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $357.65, but opened at $343.85. Bio-Rad Laboratories shares last traded at $343.85, with a volume of 231 shares.
Bio-Rad Laboratories Trading Down 3.9 %
The firm has a 50-day moving average of $338.31 and a 200 day moving average of $331.34. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The stock has a market capitalization of $9.63 billion, a price-to-earnings ratio of -12.58 and a beta of 0.73.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Further Reading
- Five stocks we like better than Bio-Rad Laboratories
- What is a support level?
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- ETF Screener: Uses and Step-by-Step Guide
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
